Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.

M. Unoki; J. Brunet; M. Mousli

Article Dans Une Revue Biochemical Pharmacology Année : 2009

Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.

, , (1)

1

M. Unoki

Fonction : Auteur

J. Brunet

Fonction : Auteur

M. Mousli

Fonction : Auteur

Laboratoire de Biophotonique et Pharmacologie - UMR 7213

Domaines

Biochimie, Biologie Moléculaire Biologie cellulaire

Ingrid Barthel : Connectez-vous pour contacter le contributeur

https://hal.science/hal-00667244

Soumis le : mardi 7 février 2012-11:40:42

Dernière modification le : vendredi 6 octobre 2023-08:50:03

Dates et versions

hal-00667244 , version 1 (07-02-2012)

Identifiants

HAL Id : hal-00667244 , version 1

Citer

M. Unoki, J. Brunet, M. Mousli. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.. Biochemical Pharmacology, 2009, 78, pp.1279-1288. ⟨hal-00667244⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS SITE-ALSACE

26 Consultations

0 Téléchargements

Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.

Domaines

Dates et versions

Identifiants

Citer

Exporter

Collections

Partager